PrimeVigilance is delighted to welcome Sally Amanuel as the new President of PrimeVigilance Ltd.

Sally has a proven track record in driving transformational changes and delivering business results in highly regulated environments across Pharma, Biotech, and CRO industries. She is a people-first leader, with an unwavering commitment to quality and innovation. She is adept at building diverse and inclusive, high-performing teams. Her strength of leadership places PrimeVigilance in a commanding position to further augment its market share.

Sally shared:” I am delighted to be part of PrimeVigilance’s continued success during this dynamic period of growth. I look forward to strengthening our client partnership in our endeavour to remain the leading pharmacovigilance service provider.”

Sally is always thinking about our customers and innovative solutions that will exceed their expectations today and in the future. This combination of a growth mindset and strength of leadership will help lead PrimeVigilance forward.

Please, join us in wishing Sally the very best in her new role!

 

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services